Group One Trading
EVH icon

Group One Trading’s Evolent Health EVH Stock Holding History

Group One Trading’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.44K Sell
3,700
-1,500
-29% -$4.76K ﹤0.01% 6462
2025
Q4 		$20.8K Sell
5,200
-600
-10% -$3.33K ﹤0.01% 6310
2025
Q3 		$49.1K Sell
5,800
-1,000
-15% -$9.7K ﹤0.01% 5982
2025
Q2 		$76.6K Buy
6,800
+3,700
+119% +$34K ﹤0.01% 5207
2025
Q1 		$29.4K Sell
3,100
-52,000
-94% -$525K ﹤0.01% 5552
2024
Q4 		$620K Sell
55,100
-166,300
-75% -$2.92M ﹤0.01% 2991
2024
Q3 		$6.26M Buy
221,400
+131,700
+147% +$3.39M 0.02% 873
2024
Q2 		$1.72M Buy
89,700
+59,500
+197% +$1.52M 0.01% 1581
2024
Q1 		$990K Sell
30,200
-140,600
-82% -$4.49M ﹤0.01% 2096
2023
Q4 		$5.64M Buy
170,800
+155,600
+1,024% +$4.4M 0.01% 1041
2023
Q3 		$414K Buy
15,200
+10,300
+210% +$286K ﹤0.01% 3100
2023
Q2 		$148K Buy
4,900
+400
+9% +$12.9K ﹤0.01% 4242
2023
Q1 		$146K Sell
4,500
-200
-4% -$6.33K ﹤0.01% 3958
2022
Q4 		$132K Sell
4,700
-26,400
-85% -$757K ﹤0.01% 4192
2022
Q3 		$1.12M Buy
31,100
+8,000
+35% +$282K ﹤0.01% 2463
2022
Q2 		$709K Buy
23,100
+900
+4% +$26.2K ﹤0.01% 3099
2022
Q1 		$717K Buy
22,200
+5,000
+29% +$131K ﹤0.01% 3435
2021
Q4 		$476K Sell
17,200
-77,800
-82% -$2.23M ﹤0.01% 4184
2021
Q3 		$2.94M Buy
95,000
+86,200
+980% +$2.07M ﹤0.01% 2262
2021
Q2 		$186K Sell
8,800
-3,400
-28% -$68.1K ﹤0.01% 5316
2021
Q1 		$246K Buy
12,200
+10,400
+578% +$198K ﹤0.01% 4802
2020
Q4 		$29K Buy
+1,800
New +$23.8K ﹤0.01% 5314
2020
Q2 		– Sell
-17,800
Closed -$97K – 5875
2020
Q1 		$97K Sell
17,800
-69,700
-80% -$623K ﹤0.01% 3322
2019
Q4 		$792K Buy
+87,500
New +$711K 0.01% 2082
2019
Q3 		– Sell
-14,000
Closed -$111K – 5255
2019
Q2 		$111K Buy
+14,000
New +$166K ﹤0.01% 3276
2019
Q1 		– Sell
-3,800
Closed -$76K – 4960
2018
Q4 		$76K Buy
+3,800
New +$87.9K ﹤0.01% 3330
2018
Q1 		– Sell
-20,000
Closed -$246K – 4955
2017
Q4 		$246K Sell
20,000
-53,100
-73% -$749K ﹤0.01% 2797
2017
Q3 		$1.3M Buy
+73,100
New +$1.51M 0.01% 1370
2016
Q4 		– Sell
-500
Closed -$12K – 4517
2016
Q3 		$12K Hold
500
– – ﹤0.01% 3986
2016
Q2 		$10K Buy
+500
New +$6.87K ﹤0.01% 4072

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's EVH Position: Q1 2026 in Review

Group One Trading sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 3,591 shares — an estimated $11.4K sold.

Group One Trading first reported a position in EVH in Q4 2015 and held it in 27 quarters. The position peaked at $3.8M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Group One Trading reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,591 Evolent Health shares in Q1 2026, an estimated $11.4K.
  • Group One Trading first reported a position in Evolent Health in Q4 2015 and held it in 27 quarters.
  • Group One Trading's Evolent Health position peaked at $3.8M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.